Childhood MASLD Prevalence Rates Have Been Measured
Researchers analyzed data from 9,352 children globally to estimate the prevalence of metabolic dysfunction-associated steatotic liver disease.
Updated on Oct. 12, 2026 in Children’s Health
Live Poll
Should pediatric health screenings be expanded in your area given rising rates of liver disease?
A global study has revealed that 17.60% of children in the community population suffer from metabolic dysfunction-associated steatotic liver disease (MASLD). The prevalence jumps to 58.03% among children evaluated in hospital settings.
Why it matters
This study addresses the uncertainty surrounding the worldwide prevalence of pediatric MASLD. Understanding these rates is essential for identifying risk factors and managing chronic liver health in younger populations.
The study utilized vibration-controlled transient elastography to examine 9,352 participants aged 6-18 years. Researchers found a 17.60% MASLD prevalence in community populations, significantly lower than the 58.03% found in hospitals.
The details
The study spanned 38 research centers across 17 countries on five continents to track the condition. Findings indicate that factors such as obesity, older age, and elevated serum aminotransferase levels are closely linked to the presence of hepatic steatosis and fibrosis.
Timeline
The study compared data between the 2017-2020 and 2021-2024 reference periods.
Research findings were released on October 12, 2026.
Health Landscape
The widespread implementation of vibration-controlled transient elastography (VCTE) is transforming how researchers map liver disease prevalence globally. This study bridges gaps in pediatric health data by providing a standardized metric across diverse international populations.
The study highlights a clear correlation between obesity and MASLD, suggesting that families should prioritize monitoring liver health through regular check-ups. Identifying these prevalence rates helps medical providers advocate for earlier lifestyle interventions and diagnostic screenings.
The takeaway
Maintaining a healthy weight and monitoring liver enzymes are critical steps for protecting children against the progression of MASLD. Families should discuss metabolic health with their pediatricians to determine if diagnostic screenings are appropriate for their child.
Further reading
For more on pediatric health trends, visit the Children’s Health section.
Source note: This article includes information reported by Nature.
Live Poll
Should pediatric health screenings be expanded in your area given rising rates of liver disease?
